FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000637969> ?p ?o ?g. }

• W2000637969 endingPage "420" @default.
• W2000637969 startingPage "413" @default.
• W2000637969 abstract "Rituximab is a humanized chimeric monoclonal antibody, targeted against the pan B cell marker CD20. It is frequently used to treat a variety of B cell lymphomas and immunosuppression associated lymphoproliferations such as posttransplant lymphoproliferative disorder (PTLD). The response rate of rituximab treatment is 65%, but the exact in vivo mechanism of action is not yet fully understood, although antibody-dependent cell-mediated cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), and direct induction of apoptosis have been suggested as effector mechanism. Rituximab may affect different types of lymphomas through different mechanisms. As lymphoblastoid cell lines (LCLs) are well-established in vitro models of PTLD, we investigated the effect of rituximab on these cells using a custom built automated laser confocal fluorescent microscope. We found that rituximab alone was not effective at inducing cell death of EBV-transformed B cells. The antibody was effective in the complement-mediated CDC. Rituximab could induce NK cell-mediated ADCC but it was more effective in the presence of untreated fresh human plasma compared to heat-inactivated human plasma. Our data suggest that complement-enhanced NK-mediated ADCC is required for effective rituximab mediated killing of EBV-transformed B cells. Determining and monitoring of serum complement levels and in vitro killing efficacy of NK cells of PTLD patients might help to predict resistant cases to rituximab therapy. On the other hand our results suggest a possibility that rituximab should be combined only with cytotoxic drugs that spare NK function when treating PTLD patients." @default.
• W2000637969 created "2016-06-24" @default.
• W2000637969 creator A5000872486 @default.
• W2000637969 creator A5026562212 @default.
• W2000637969 creator A5029928308 @default.
• W2000637969 creator A5040747013 @default.
• W2000637969 creator A5056761943 @default.
• W2000637969 creator A5060660547 @default.
• W2000637969 creator A5084791326 @default.
• W2000637969 creator A5087933217 @default.
• W2000637969 creator A5090282208 @default.
• W2000637969 date "2009-07-01" @default.
• W2000637969 modified "2023-10-17" @default.
• W2000637969 title "NK cell-mediated lysis is essential to kill Epstein–Barr virus transformed lymphoblastoid B cells when using rituximab" @default.
• W2000637969 cites W147398146 @default.
• W2000637969 cites W1496775914 @default.
• W2000637969 cites W1531680230 @default.
• W2000637969 cites W1653904273 @default.
• W2000637969 cites W1779409385 @default.
• W2000637969 cites W1855945624 @default.
• W2000637969 cites W1925602349 @default.
• W2000637969 cites W1933173616 @default.
• W2000637969 cites W1973910785 @default.
• W2000637969 cites W1975401834 @default.
• W2000637969 cites W1976835009 @default.
• W2000637969 cites W1977778943 @default.
• W2000637969 cites W1979419663 @default.
• W2000637969 cites W1983339176 @default.
• W2000637969 cites W1984322725 @default.
• W2000637969 cites W1987870078 @default.
• W2000637969 cites W1988441535 @default.
• W2000637969 cites W2005359323 @default.
• W2000637969 cites W2010690729 @default.
• W2000637969 cites W2017481940 @default.
• W2000637969 cites W2022588086 @default.
• W2000637969 cites W2030299802 @default.
• W2000637969 cites W2033485934 @default.
• W2000637969 cites W2035277855 @default.
• W2000637969 cites W2040426470 @default.
• W2000637969 cites W2042502384 @default.
• W2000637969 cites W2044360617 @default.
• W2000637969 cites W2057796652 @default.
• W2000637969 cites W2059949924 @default.
• W2000637969 cites W2061048050 @default.
• W2000637969 cites W2066485964 @default.
• W2000637969 cites W2068033067 @default.
• W2000637969 cites W2069524809 @default.
• W2000637969 cites W2069834626 @default.
• W2000637969 cites W2080501134 @default.
• W2000637969 cites W2088332148 @default.
• W2000637969 cites W2120224373 @default.
• W2000637969 cites W2124910438 @default.
• W2000637969 cites W2129664415 @default.
• W2000637969 cites W2130901389 @default.
• W2000637969 cites W2134297634 @default.
• W2000637969 cites W2141139539 @default.
• W2000637969 cites W2162538131 @default.
• W2000637969 cites W2170938637 @default.
• W2000637969 cites W33733012 @default.
• W2000637969 cites W4235943459 @default.
• W2000637969 cites W4293245634 @default.
• W2000637969 cites W61415573 @default.
• W2000637969 doi "https://doi.org/10.1016/j.biopha.2008.08.009" @default.
• W2000637969 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18834693" @default.
• W2000637969 hasPublicationYear "2009" @default.
• W2000637969 type Work @default.
• W2000637969 sameAs 2000637969 @default.
• W2000637969 citedByCount "11" @default.
• W2000637969 countsByYear W20006379692014 @default.
• W2000637969 countsByYear W20006379692015 @default.
• W2000637969 countsByYear W20006379692020 @default.
• W2000637969 countsByYear W20006379692021 @default.
• W2000637969 countsByYear W20006379692023 @default.
• W2000637969 crossrefType "journal-article" @default.
• W2000637969 hasAuthorship W2000637969A5000872486 @default.
• W2000637969 hasAuthorship W2000637969A5026562212 @default.
• W2000637969 hasAuthorship W2000637969A5029928308 @default.
• W2000637969 hasAuthorship W2000637969A5040747013 @default.
• W2000637969 hasAuthorship W2000637969A5056761943 @default.
• W2000637969 hasAuthorship W2000637969A5060660547 @default.
• W2000637969 hasAuthorship W2000637969A5084791326 @default.
• W2000637969 hasAuthorship W2000637969A5087933217 @default.
• W2000637969 hasAuthorship W2000637969A5090282208 @default.
• W2000637969 hasConcept C109316439 @default.
• W2000637969 hasConcept C159654299 @default.
• W2000637969 hasConcept C18031839 @default.
• W2000637969 hasConcept C202751555 @default.
• W2000637969 hasConcept C203014093 @default.
• W2000637969 hasConcept C2522874641 @default.
• W2000637969 hasConcept C2777726029 @default.
• W2000637969 hasConcept C2780653079 @default.
• W2000637969 hasConcept C2781375147 @default.
• W2000637969 hasConcept C40677261 @default.
• W2000637969 hasConcept C502942594 @default.
• W2000637969 hasConcept C542903549 @default.
• W2000637969 hasConcept C55493867 @default.
• W2000637969 hasConcept C86803240 @default.
• W2000637969 hasConceptScore W2000637969C109316439 @default.

• next